Key result
Right subclavian artery plaques linked to ~143% higher CV event risk in essential hypertension.
Why the study?
Subclinical atherosclerosis may predict future cardiovascular events, but existing carotid subclinical atherosclerotic markers have limited value.
Does the presence of subclavian artery plaques predict future cardiovascular events in hypertensive patients without clinical atherosclerotic diseases?
Cohort (n=473)
No
Does the presence of subclavian artery plaques predict future cardiovascular events in hypertensive patients without clinical atherosclerotic diseases?
Odds Ratio: 2.428 (95% CI 1.098–5.37)
Absolute Event Rate: 11.9% vs 4.4%
p-value: p=0.028
The presence of right subclavian artery plaques, particularly when combined with carotid plaques, independently predicts future cardiovascular events in hypertensive patients without known clinical atherosclerotic disease.
BackgroundAtherosclerosis is one of the leading contributors to cardiovascular diseases. Subclinical atherosclerosis could occur long time before the presence of clinical symptoms and may have predictive value for future cardiovascular events. Existing carotid subclinical atherosclerotic markers have limited value.Subjects and MethodsPatients admitted to the cardiac vascular center of Beijing Tiantan Hospital due to essential hypertension were prospectively consecutively enrolled. Those with histories of coronary artery disease (CAD), cerebrovascular diseases, and significant stenosis of main arteries were excluded. Patients diagnosed with carotid and/or subclavian artery stenosis were also excluded after admission. All participants received a series of routine blood test at admission into hospital and ultrasonic examinations of bilateral carotid arteries and right subclavian artery. All data were recorded. After discharged from hospital all participants were followed up with cardiovascular events, including death, hear failure, myocardial infarction, unstable angina pectoris and stroke.Results473 participants were finally involved in the study, including 284 men and 189 women.9/473 (8.2%, 95%C.I. [5.9-11.1%] participants suffered from endpoint events, including 19(4.0%) cases of myocardial infarction (15 undergoing PCI and 5 death), 4(0.8%) heart failure (all also involved in the myocardial infarction group), 3(0.6%) ischemic stroke (1 death), and 17(3.6%) angina pectoris (7 undergoing PCI). No death due to other reasons was recorded. After the adjustment of potential risk factors based on the results of univariate analyses, the prevalence of right subclavian plaque (RSP) (OR=2.428, 95%C.I. [1.098, 5.370], p=0.028) and both carotid and subclavian plaques (MPs) (OR = 3.539, 95%C.I. [1.547, 8.096], p = 0.003) were both significantly associated with endpoint events. Globulin and albumin had significantly correlations with future events despite the atherosclerotic marker used in the regression model.ConclusionThe prevalence of right subclavian plaques was independently significantly associated with the incidence of future cardiovascular events in the cohort. Higher level of globulin and lower level of albumin tended to be predictors for future events. Combination of both right subclavian artery and carotid artery atherosclerotic plaques may have strongest predictive value for future cardiovascular events in the hypertensive cohort without clinical atherosclerotic diseases.
No takes yet. Share an insight, caveat, or question.
Mu et al. (2021) conducted a cohort in Essential hypertension (n=473). Right subclavian artery plaques vs. Absence of right subclavian artery plaques was evaluated on Cardiovascular events (death, heart failure, myocardial infarction, unstable angina pectoris, and stroke) (OR 2.428, 95% CI 1.098-5.370, p=0.028). The presence of right subclavian artery plaques was independently associated with an increased risk of future cardiovascular events (OR 2.428) in patients with essential hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: